Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice-Reference-Cited by-同舟云学术

Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice

Published:2021-07 Issue:4 Volume:36 Page:109450
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Martinez David R.,Schäfer Alexandra,Leist Sarah R.,Li Dapeng,Gully Kendra,Yount Boyd,Feng Joy Y.,Bunyan Elaine,Porter Danielle P.,Cihlar Tomas,Montgomery Stephanie A.,Haynes Barton F.,Baric Ralph S.,Nussenzweig Michel C.,Sheahan Timothy P.

Funder

National Institutes of Health

National Cancer Institute

National Institute of Allergy and Infectious Diseases

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference44 articles.

1. A neutralizing monoclonal antibody for hospitalized patients with Covid-19;N. Engl. J. Med.,2021

2. Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease;Agostini;mBio,2018

3. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies;Barnes;Nature,2020

4. Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies;Barnes;Cell,2020

5. Remdesivir for the Treatment of Covid-19 - Final Report;Beigel;N. Engl. J. Med.,2020

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody drugs targeting SARS-CoV-2: Time for a rethink?;Biomedicine & Pharmacotherapy;2024-07

2. The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronaviruses;Science Translational Medicine;2024-05-22

3. Natural Killer Cell‐Derived Extracellular Vesicles as Potential Anti‐Viral Nanomaterials;Advanced Healthcare Materials;2024-05-02

4. SARS-CoV-2 resistance to monoclonal antibodies and small-molecule drugs;Cell Chemical Biology;2024-04

5. Divergent pathogenetic outcomes in BALB/c mice following Omicron subvariant infection;Virus Research;2024-03